Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: Formulation, uptake mechanism, internalization kinetics, and subcellular localization

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 4763-4781

  Korang Yeboah, Maxwell ^a   Gorantla, Yamini ^a   Paulos, Simon A ^a   Sharma, Pankaj ^b   Chaudhary, Jaideep ^b   Palaniappan, Ravi ^a  

^a MERCER UNIVERSITY   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

Clathrin mediated endocytosis; Endocytosis; Macropinocytosis; Prostate cancer; Subcellular targeting

Indexed keywords

CHLORPROMAZINE; CLATHRIN; COUMARIN; COUMARIN 6; DRUG CARRIER; MALTODEXTRIN; POLYCAPROLACTONE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; NANOPARTICLE; POLYESTER; POLYSACCHARIDE;

ARTICLE; BIOCOMPATIBILITY; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UPTAKE; ENCAPSULATION; ENDOCYTOSIS; FREEZE DRYING; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; MELTING POINT; PARTICLE SIZE; PINOCYTOSIS; PROSTATE CANCER; PROSTATE EPITHELIUM CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; CHEMISTRY; INTRACELLULAR SPACE; METABOLISM; NANOTECHNOLOGY; TUMOR CELL LINE;

BOVINAE;

CELL LINE, TUMOR; DRUG CARRIERS; HUMANS; INTRACELLULAR SPACE; NANOPARTICLES; NANOTECHNOLOGY; POLYESTERS; POLYSACCHARIDES;

EID: 84938297501     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S75101     Document Type: Article

References (63)

1. Almouazen E, Bourgeois S, Boussaïd A, et al. Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages. Int J Pharm. 2012;430(1-2):207-215.
2. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2(5):347-360.
3. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
4. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771-782.
5. Mosqueira VC, Legrand P, Gulik A, et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials. 2001;22(22):2967-2979.
6. Nowacek AS, Balkundi S, McMillan J, et al. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J Control Release. 2011;150(2):204-211.
7. Liu J, Bauer H, Callahan J, Kopecková P, Pan H, Kopecek J. Endocytic uptake of a large array of HPMA copolymers: elucidation into the dependence on the physicochemical characteristics. J Control Release. 2010;143(1):71-79.
8. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105(33):11613-11618.
9. Pangarkar C, Dinh A-T, Mitragotri S. Endocytic pathway rapidly delivers internalized molecules to lysosomes: an analysis of vesicle trafficking, clustering and mass transfer. J Control Release. 2012;162(1):76-83.
10. Kaplan J. Cell contact induces an increase in pinocytotic rate in cultured epithelial cells. Nature. 1976;263(5578):596-597.
11. Snijder B, Sacher R, Rämö P, Damm E-M, Liberali P, Pelkmans L. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature. 2009;461(7263):520-523.
12. Barua S, Rege K. Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small. 2009;5(3):370-376.
13. Woodruff MA, Hutmacher DW. The return of a forgotten polymer - polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217-1256.
14. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278(1):1-23.
15. Williams JM, Adewunmi A, Schek RM, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials. 2005;26(23):4817-4827.
16. Jaiswal J, Kumar Gupta S, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J Control Release. 2004;96(1):169-178.
17. Dash TK, Konkimalla VB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release. 2012;158(1):15-33.
18. Chawla JS, Amiji MM. Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 2002;249(1-2):127-138.
19. Corveleyn S, Remon JP. Maltodextrins as lyoprotectants in the lyophilization of a model protein, LDH. Pharm Res. 1996;13(1):146-150.
20. Dekeyser PM, Corveleyn S, Demeester J, Remon J-P. Stabilization of fully active chymopapain by lyophilization. Int J Pharm. 1997;159(1):19-25.
21. Devineni D, Ezekwudo D, Palaniappan R. Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA. J Microencapsul. 2007;24(4):358-370.
22. Boyd LK, Mao X, Lu Y-J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol. 2012;9(11):652-664.
23. LaTulippe E, Satagopan J, Smith A, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002;62(15):4499-4506.
24. Apodaca G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic. 2001;2(3):149-159.
25. Bonaccorsi L, Nosi D, Muratori M, Formigli L, Forti G, Baldi E. Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines. J Mol Endocrinol. 2007;38(1-2):51-66.
26. Tilley WD, Wilson CM, Marcelli M, McPhaul MJ. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 1990;50(17):5382-5386.
27. Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res. 1999;59(8):1987-1993.
28. Subtil A, Gaidarov I, Kobylarz K, Lampson MA, Keen JH, McGraw TE. Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc Natl Acad Sci U S A. 1999;96(12):6775-6780.
29. Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol. 2003;161(4):673-677.
30. Imelli N, Meier O, Boucke K, Hemmi S, Greber UF. Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. J Virol. 2004;78(6):3089-3098.
31. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell. 1999;10(4):961-974.
32. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol. 1993;123(5):1107-1117.
33. Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol. 2008;440:15-33.
34. Iversen T-G, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 2011;6(2):176-185.
35. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182-195.
36. Koivusalo M, Welch C, Hayashi H, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547-563.
37. Kälin S, Amstutz B, Gastaldelli M, et al. Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol. 2010;84(10):5336-5350.
38. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000;196(2):177-182.
39. Win KY, Feng S-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(15):2713-2722.
40. Jin H, Heller DA, Sharma R, Strano MS. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano. 2009;3(1):149-158.
41. Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S. Size-dependent endocytosis of nanoparticles. Adv Mater. 2009;21:419-424.
42. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem. 2010;21(5):797-802.
43. Awasthi VD, Garcia D, Goins BA, Phillips WT. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm. 2003;253(1-2):121-132.
44. Wang X, Wang Y, Wei K, Zhao N, Zhang S, Chen J. Drug distribution within poly(ε-caprolactone) microspheres and in vitro release. J Mater Process Technol. 2009;209(1):348-354.
45. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials. 2001;22(3):231-241.
46. Dubernet C. Thermoanalysis of microspheres. Thermochim Acta. 1995;248:259-269.
47. Elnaggar YSR, El-Massik MA, Abdallah OY, Ebian AER. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process. AAPS Pharm Sci Tech. 2010;11(2):645-651.
48. Myers SL, Shively ML. Solid-state emulsions: the effects of maltodextrin on microcrystalline aging. Pharm Res. 1993;10(9):1389-1391.
49. Eley JG, Pujari VD, McLane J. Poly(lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution. Drug Deliv. 2004;11(4):255-261.
50. Roger E, Kalscheuer S, Kirtane A, et al. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Mol Pharm. 2012;9(7):6-13.
51. Dong Y, Feng S-S. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(30):6068-6076.
52. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-1033.
53. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11-20.
54. Verma A, Uzun O, Hu Y, et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2013;12(4):376-376.
55. Thurn KT, Arora H, Paunesku T, et al. Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine. 2011;7(2):123-130.
56. Paillard A, Hindré F, Vignes-Colombeix C, Benoit J-P, Garcion E. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials. 2010;31(29):7542-7554.
57. Brickman MJ, Cook JM, Balber AE. Low temperature reversibly inhibits transport from tubular endosomes to a perinuclear, acidic compartment in African trypanosomes. J Cell Sci. 1995;108(1):3611-3621.
58. Steinman RM, Mellman IS, Muller WA, Cohn ZA. Endocytosis and the recycling of plasma membrane. J Cell Biol. 1983;96(1):1-27.
59. Tomoda H, Kishimoto Y, Lee YC. Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages. J Biol Chem. 1989;264(26):15445-15450.
60. Trajkovska M. Macropinocytosis supports cancer cell proliferation. Nat Cell Biol. 2013;15(7):729-729.
61. Commisso C, Davidson SM, Soydaner-Azeloglu RG, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497(7451):633-637.
62. Neves V, Gerondopoulos A, Tîlmaciu C, et al. Cellular localization, accumulation and trafficking of DWNTs in human prostate cancer cells. Nano Res. 2012;5(4):223-234.
63. Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002;16(10):1217-1226.